Skip to main content
NANOSONICS LIMITED logo

NANOSONICS LIMITED — Investor Relations & Filings

Ticker · NAN ISIN · AU000000NAN9 LEI · 549300XUBCM70BRANN81 ASX Manufacturing
Open in API
Filings indexed 1,048 across all filing types
Latest filing 2010-08-12 Share Issue/Capital Cha…
Country AU Australia
Listing ASX NAN

About NANOSONICS LIMITED

https://www.nanosonics.com.au

Nanosonics Limited is a medical technology company specializing in the development and commercialization of infection prevention solutions. The company's flagship product, the trophon system, provides automated high-level disinfection (HLD) for ultrasound probes. Utilizing a proprietary hydrogen peroxide mist technology, the trophon device ensures consistent and effective disinfection of both the probe handle and shaft, addressing the risks of cross-contamination in clinical settings. The system is designed to integrate into diagnostic workflows, offering a faster and more environmentally sustainable alternative to traditional manual chemical soaking methods. Nanosonics continues to expand its portfolio with digital traceability tools and audit-ready reporting software to enhance compliance and patient safety across global healthcare facilities.

Recent filings

Filing Released Lang Actions
Share Options granted 16 pages ?Kb
Share Issue/Capital Change Classification · 100% confidence The document is a detailed announcement from Nanosonics Limited regarding the granting of share options under the Employee Share Option Plan (ESOP) to executives and other personnel. It includes specifics about the number of options, exercise prices, vesting conditions, and references to shareholder approvals. The document also contains an Appendix 3B, which is a New Issue Announcement form used for notifying the Australian Securities Exchange (ASX) about new securities issued or to be issued. The content focuses on share option grants and related securities issuance details rather than financial results, management commentary, or regulatory certifications. It is not a full financial report, earnings release, or management discussion. The document is a formal announcement of a capital change event (share options granted and new issue announcement) and includes regulatory appendices related to securities issuance. Therefore, the most appropriate classification is Share Issue/Capital Change (SHA). The document length and detail confirm it is not a brief announcement or a report publication announcement but a substantive filing about capital changes.
2010-08-12 English
Resignation of CFO 1 page ?Kb
Board/Management Information Classification · 100% confidence The document is a short announcement dated 10th August 2010 from Nanosonics Limited, stating the resignation of the Chief Financial Officer and Company Secretary. It includes no financial data, no report or presentation, and no regulatory certification. It is clearly an announcement about a change in senior management. Therefore, it fits the category of Board/Management Information (MANG). The document length is only 1611 characters, which is consistent with a brief announcement rather than a detailed report.
2010-08-09 English
Business update and App 4C Quarterly cashflow statement 6 pages ?Kb
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Business Update and Quarterly Cashflow Statement – Appendix 4C' and includes detailed financial data for the quarter ended 30 June 2010. It contains a consolidated statement of cash flows, cash flow related to operating, investing, and financing activities, reconciliation of cash, and compliance statements. The presence of the Appendix 4C quarterly report format, detailed financial figures, and the quarterly period reference clearly indicate this is a quarterly financial report. The document is over 10,000 characters, so it is not a brief announcement or a report publication notice. It contains substantive financial data and analysis for a period shorter than a full fiscal year, consistent with the definition of an Interim / Quarterly Report (IR). Therefore, the correct classification is IR with high confidence. Q4 2010
2010-07-28 English
Update on production and FDA application 2 pages ?Kb
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 29 June 2010, providing an update on production and FDA application status for a medical device product. It discusses operational updates, production scaling, and regulatory progress with the FDA, but does not contain financial statements, detailed financial results, or formal report content. The length is short (2752 characters), and the content is an operational and regulatory update rather than a formal financial report or filing. There is no indication of a shareholder meeting, voting results, or executive changes. It is not a call transcript, earnings release, or capital update. The document fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement and operational update that does not fit other specific categories.
2010-06-28 English
Change in Director`s interest 3 pages ?Kb
Director's Dealing Classification · 100% confidence The document is a notice titled 'Change in Director’s Interests' for Nanosonics Limited, dated 11th June 2010. It includes detailed information about changes in shareholdings of a director, Dr David Fisher, including specifics of share transfers and in-specie distributions. The document references Appendix 3Y, which is a standard form used for reporting changes in directors' interests in securities to the Australian Securities Exchange (ASX). There is no financial performance data, earnings information, or management discussion. The content is focused solely on insider share transactions by a company director. Therefore, this document fits the category of Director's Dealing (DIRS). The document length and detail support a confident classification.
2010-06-10 English
Changes in Directors Interests - App 3Ys 5 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Changes in Director’s Interests' and includes multiple 'Appendix 3Y' notices, which are standard forms used to report changes in directors' relevant interests in securities under ASX listing rules. The content details specific shareholdings and transactions by directors, including dates, number of shares acquired, and nature of the transactions. There is no financial performance data, earnings information, or management discussion. The document is a regulatory announcement about insider share transactions by directors, fitting the definition of Director's Dealing filings. The document length (7817 characters) supports it being a full notice rather than a brief announcement. Therefore, the correct classification is 'DIRS' (Director's Dealing).
2010-06-07 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.